Literature DB >> 7379805

Modifying effect of commercially available stannous pyrophosphate (PYRO-Sn) on the tissue affinity of 99mTc pertechnetate.

Z Bałtrukiewicz, J Przedlacki, E Dziuk.   

Abstract

Investigations were performed to examine the conditions required for in vivo labelling of red blood cells (RBCs) with 99mTc after injection of stannous pyrophosphate. It was found that good in vivo labelling of RBCs is possible and that the efficacy of this procedure is high. The highest concentration of 99mTc in the blood occurred in the first 2 h after pertechnetate injection, and the optimum time between stannous pyrophosphate and pertechnetate injection ranged from 10 to 30 min.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7379805     DOI： 10.1007/bf00261206

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  11 in total

1.  A simple kit for the preparation of 99mTc-labeled red blood cells.

Authors:  T D Smith; P Richards
Journal:  J Nucl Med       Date:  1976-02       Impact factor: 10.057

2.  A comparative evaluation of techniques for rapid and efficient in vivo labeling of red cells with [99mTc] pertechnetate.

Authors:  R G Hamilton; P O Alderson
Journal:  J Nucl Med       Date:  1977-10       Impact factor: 10.057

3.  Serial radionuclide determinations of the electron fraction with 99mTc-labeled red blood cells.

Authors:  P O Alderson; D R Bernier; P A Ludbrook; J F Harwig; R Roberts; B E Sobel
Journal:  Radiology       Date:  1976-06       Impact factor: 11.105

4.  Alterations in tissue distribution of 99mTc-pertechnetate in rats given stannous tin.

Authors:  J McRae; R M Sugar; B Shipley; G R Hook
Journal:  J Nucl Med       Date:  1974-03       Impact factor: 10.057

5.  Gated blood pool imaging following 99mTc stannous pyrophosphate imaging.

Authors:  E M Stokely; R W Parkey; F J Bonte; K D Graham; M J Stone; J T Willerson
Journal:  Radiology       Date:  1976-08       Impact factor: 11.105

6.  Technetium-99m labeling by means of stannous pyrophosphate: application to bleomycin and red blood cells.

Authors:  A Bardy; H Douyé; R Gobin; J Beydon; G de Tovar; C Pannecière; M Hégésippe
Journal:  J Nucl Med       Date:  1975-05       Impact factor: 10.057

7.  Technetium-99m as a label for erythrocytes.

Authors:  J Fischer; R Wolf; A Leon
Journal:  J Nucl Med       Date:  1967-03       Impact factor: 10.057

8.  Effects of prior administration of Sn(II) complexes on in vivo distribution of 99mTc-pertechnetate.

Authors:  A Khentigan; M Garrett; D Lum; H S Winchell
Journal:  J Nucl Med       Date:  1976-05       Impact factor: 10.057

9.  In vivo labeling of red blood cells with 99mTc: a new approach to blood pool visualization.

Authors:  D G Pavel; M Zimmer; V N Patterson
Journal:  J Nucl Med       Date:  1977-03       Impact factor: 10.057

10.  In vitro technetium-99m red blood cell labeling using commercial stannous pyrophosphate.

Authors:  A M Zimmer
Journal:  Am J Hosp Pharm       Date:  1977-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.